AVAH NASDAQ Week ended 11 Sep 2026

Weekly Investor Report

Aveanna Healthcare Holdings Inc ยท Healthcare ยท Medical Care Facilities

Latest close 14.08 USD
3.7% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 64.6% above the Trend Line and sits at 94.6% of its 52-week range. The latest completed week returned 3.7%, after a 14.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 55/100. Near-term considerations: price is close to its 52-week high; earnings are due in 47d.

Setup score 67 out of 100
Latest Close 14.08 USD 11 Sep 2026
1W Return 3.7% latest completed week
4W Return 14.3% short-term follow-through
12W Return 80.7% quarterly tape
Trend Breadth 57.7% 30 of 52 weeks active
Volume Ratio 1.1x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 6 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 ยท Price action

Where price isโ€”and whether the trend supports it

The weekly trend is active. Price is 64.6% above the Trend Line and sits at 94.6% of its 52-week range. The latest completed week returned 3.7%, after a 14.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 ยท Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.1x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug 14 Aug 21 Aug 28 Aug 4 Sep 11 Sep
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9012-week average 0.55

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.90Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers66 reversal markers

No recent accumulation markers. 6 reversal markers.

03 ยท Momentum and leadership

Is performance persistentโ€”and is the stock leading?

Performance is 14.3% over four weeks, 80.7% over 12 weeks, and 66.8% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W3.7%
4W14.3%
12W80.7%
26W102.3%
52W66.8%
Active trend streak8 weeks
Active weeks in one year30
Trend breadth57.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.72Latest activity-pressure read.
Pressure change32.7%Four-week change in activity pressure.
Leadership47.89Latest relative-leadership reading.
RS change58.4%Four-week change in relative leadership.
04 ยท Fundamentals and valuation

What investors are paying forโ€”and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 11 Sep 2026 Financial statements through 30 Jun 2026 Field coverage 94% Model confidence 94%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength66/100Blend of value, momentum, and quality. Underlying universe rank 35; rank 1 is best.
Value34/100Relative valuation strength. Underlying universe rank 67; rank 1 is best.
Quality75/100Profitability and accounting quality. Underlying universe rank 26; rank 1 is best.
Momentum90/100Medium-term price momentum. Underlying universe rank 11; rank 1 is best.
Growth78/100Revenue and earnings growth. Underlying universe rank 23; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework71/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
11.2x
Price divided by trailing earnings.
Price / sales
1.2x
Market value relative to trailing revenue.
EV / EBITDA
14.6x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
3.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
32.0%
Gross profit retained from each unit of revenue.
Operating margin
11.1%
Operating profit retained from revenue.
Free-cash-flow margin
5.9%
Free cash flow generated from revenue.
Return on invested capital
12.8%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
19.5%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
97.2%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.3%
Net share repurchases relative to market value.
Shareholder yield
-0.3%
Dividend yield plus net buyback yield.
Net debt / EBITDA
4.6x
Balance-sheet debt relative to operating cash earnings.
05 ยท Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

AVAH shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.19, expected move of 8.9%, and Sharemaestro trend signal active.

Conviction59/100
Expected move8.9%
Put/call volume0.19
Pressure76
Speculation40
Volatility92
Trend agreement36
Open options detail
Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment55/100

Weighted news tone is neutral across 53 relevant articles.

23 positive ยท 18 neutral ยท 12 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 ยท Catalysts and risk

What can move the sharesโ€”and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings47dNext report is scheduled for 05 Nov 2026; event risk rises as the date approaches.
Options expected move8.9%Nearest-chain priced movement where available.
52-week drawdown-3.2%Distance below the 52-week high.
13-week volatility8.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher16 of 2610 weeks finished lower.
Best week+29.8%Week of 14 Aug.
Worst week-6.8%Week of 5 Jun.
Latest week+3.7%Week of 11 Sep.

Shape of recent returns

Strong gains9
Modest gains7
Flat weeks0
Modest losses7
Sharp losses3
Recent vol8.0%13-week weekly-return volatility.
Base vol6.8%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -3.7%Average positive week versus average negative week.
07 ยท Sector and peer context

Is this stock leadingโ€”or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 ยท Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
11 Sep 202614.08 USD3.7%8.56 USD5.52 USD1.7247.8914.9MOn
4 Sep 202613.58 USD2.0%8.35 USD5.43 USD1.7342.9112.1MOn
28 Aug 202613.32 USD1.2%8.16 USD5.36 USD1.6041.6116.7MOn
21 Aug 202613.16 USD6.8%8.00 USD5.28 USD1.4341.4323.5MOn
14 Aug 202612.32 USD29.8%7.85 USD5.20 USD1.2930.2425.3MOn
7 Aug 20269.49 USD1.1%7.74 USD5.14 USD1.222.137.9MOn
31 Jul 20269.39 USD-0.6%7.71 USD5.09 USD1.326.588.1MOn
24 Jul 20269.45 USD-2.5%7.67 USD5.04 USD1.338.9710.1MOn
17 Jul 20269.69 USD-0.1%7.64 USD4.99 USD1.3611.1010.5MOff
10 Jul 20269.70 USD6.6%7.62 USD4.94 USD1.217.7212.9MOff
3 Jul 20269.10 USD5.1%7.60 USD4.89 USD0.973.867.3MOff
26 Jun 20268.66 USD11.2%7.61 USD4.84 USD0.820.3818.5MOff
19 Jun 20267.79 USD9.9%7.63 USD4.79 USD0.56-13.357.4MOff
12 Jun 20267.09 USD6.1%7.66 USD4.75 USD0.49-18.838.2MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context